Facial edema after covid-19 ameliorated by acupuncture: A CARE-compliant case report.

Publication date: Jul 18, 2025

Covid-19-induced inflammation and edema of the facial skin is a new problem, albeit still somewhat uncommon. To date, there are no published reports on the use of acupuncture for treating facial edema caused by corona virus disease 2019 (COVID-19). The patient, a young female, developed a fever of 38. 7 ^0C, malaise, and headache, followed by facial edema. After 3 months of conventional treatments (i. e., oral hydroxychloroquine and ebastine) failed, she turned to acupuncture. Facial edema after COVID-19. Acupuncture points on the face (ST2, ST3, ST4, LI20, and SI18), facial acupuncture with multiple micro-needles in the affected area, and distal acupuncture points on LI11, LI4, LI6, SP9, ST36, ST40, and LR3. The patient was treated with acupuncture in 20 sessions over 2 months (3 times a week for the first month, 2 times a week for the second month) and instructed not to use any medication during and after the treatment of acupuncture. After 2 months of acupuncture treatment, the facial edema of the patient subsided. This case suggests that acupuncture may be an effective alternative therapy for superficial skin inflammation and edema caused by viral infections like COVID-19. Further studies are warranted to explore acupuncture’s role in managing post-viral inflammatory conditions.

Open Access PDF

Concepts Keywords
Covid acupuncture
Female Acupuncture Therapy
Hydroxychloroquine Adult
Therapy case report
Virus COVID-19
covid-19
Edema
Face
facial edema
Female
Humans
SARS-CoV-2

Semantics

Type Source Name
disease MESH edema
disease MESH covid-19
disease MESH inflammation
disease MESH virus disease
drug DRUGBANK Hydroxychloroquine
drug DRUGBANK Ebastine
disease IDO role
disease MESH severe acute respiratory syndrome
disease IDO susceptibility
disease MESH infections
disease MESH urticaria
disease MESH blisters
drug DRUGBANK Coenzyme M
pathway REACTOME Reproduction
disease MESH measles
pathway KEGG Measles
disease IDO infection
disease MESH long COVID
disease MESH critically ill
disease MESH arthritis
disease MESH sequelae
disease IDO history
disease MESH influenza
disease MESH dyspnea
disease MESH rosacea
disease MESH acne
disease IDO blood
disease MESH anxiety
drug DRUGBANK Acetaminophen
disease IDO pathogen
disease IDO toxin
pathway REACTOME Metabolism
disease MESH Depression
disease MESH erythema
drug DRUGBANK Cysteamine
disease MESH telangiectasia
disease MESH oxidative stress
drug DRUGBANK Angiotensin II
disease MESH fibrosis
pathway REACTOME Apoptosis
drug DRUGBANK Water
drug DRUGBANK Minocycline
disease MESH dry eyes
drug DRUGBANK Doxycycline
drug DRUGBANK Aspartame

Original Article

(Visited 1 times, 1 visits today)